Skip to content

New study shows importance of Covid-19 vaccines in patients who have had a kidney transplant

New study shows importance of Covid-19 vaccines in patients who have had a kidney transplant 23 February 2023 The MELODY study, co-funded by Kidney Research UK, involved more than 28,000 immunocompromised patients across the UK, including those with solid organ transplants, patients with blood cancer and autoimmune diseases (including vasculitis and lupus). MELODY is the…

Read More

NICE U-turn gives kidney patients much needed Covid-19 treatment

NICE U-turn gives kidney patients much needed Covid-19 treatment 22 February 2023 Kidney Research UK has welcomed the revised decision by the National Institute for Health and Care Excellence (NICE) to continue access to sotrovimab (Xevudy) for the treatment of kidney disease patients who are at high risk of progressing to severe Covid-19. What is…

Read More

NICE process “not appropriate for a rapidly evolving virus”

NICE process “not appropriate for a rapidly evolving virus” 12 December 2022 We have submitted comments relating to NICE’s draft guidance on therapeutics for people with Covid-19, following the regulatory body’s draft decision to dramatically reduce the number of available treatments. We highlighted that the relevant evidence failed to consider the impact on high-risk patients…

Read More

Supporting patients for fair access to anti-virals for Covid-19

Supporting patients for fair access to anti-virals for Covid-19 16 November 2022 The National Institute for Health and Care Excellence (NICE) has today published draft recommendations to drastically reduce the number of anti-viral treatment options available for people with Covid-19. With large numbers of people on immunosuppressants or with poor kidney function left exposed by…

Read More

Making vaccinations work better for patients on dialysis

Making vaccinations work better for patients on dialysis 20 July 2022 Professor Alan Salama and his colleagues at University College London are building on their previous finding that the immune systems of dialysis patients don’t work as well as they should. We are thrilled to be able to support his work on making vaccinations work…

Read More

MELODY study update to include immunocompromised young people

MELODY study update to include immunocompromised young people 11 May 2022 We are pleased to share that we are funding an extension to the MELODY study to understand how well immunocompromised young people are protected against Covid-19 after vaccination.   What is the MELODY study?  Back in December, we shared details of the MELODY study that…

Read More

New study update to investigate how fourth doses of the Covid-19 vaccine protect immunocompromised patients

New study update to investigate how fourth doses of the Covid-19 vaccine protect immunocompromised patients 27 April 2022 As the pandemic continues and vaccine guidance is updated, it is important that we continue to monitor how well-protected kidney patients are.   We are now supporting researchers at Imperial College London to extend the MELODY study to…

Read More

Many dialysis patients remain vulnerable to Omicron

Many dialysis patients remain vulnerable to Omicron 21 January 2022 New laboratory data from our researchers working at the Francis Crick Institute, published this week as a Research Letter in The Lancet, show that, even after vaccination, patients receiving in-hospital dialysis treatment are less likely to be protected against infection by the Omicron variant.  Omicron is now…

Read More

From trauma to giving back: Jason’s Covid recovery mission

From trauma to giving back: Jason’s Covid recovery mission 27 December 2021 Wherever possible, Jason Mageehan has always tried to turn adversity into opportunity – whether arranging client meetings to coincide with dialysis sessions or viewing his kidney transplant operation as a springboard to achieving personal and business goals.   Now, therapy to deal with…

Read More
Scroll To Top